On Monday the Standard & Poor's 500 and the NASDAQ Composite hit new all-time highs on what I'm calling the Vaccine Put, the hope that we'll see the announcement of an approved coronavirus vaccine by early in 2021 or maybe even the end of 2020 or perhaps before the November elections. That would immediately lead […]
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.
